Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Clinical trial NCT07181161 · RECRUITING

Trial details

NCT number: NCT07181161
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer

Start date: 2025-10-01
Primary completion: 2029-01-18
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.